Divalproex Sodium
Product Images NDC 69189-0046

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 69189-0046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Ec 125 mg Tablet Label (6918900461)

This is a description of a medication called Divalproex EC in a 125MG Tablet form with a pink color. The manufacturer is Citron and the lot number is APF15G22- with an expiration date of 07/21/2016. The NDC number is 6918900461 and it is made by AVEFA MCKENNAN.*

FDA Label Image

Figure 1 (Divalproex Fig1)

FDA Label Image

Figure 2 (Divalproex Fig2)

FDA Label Image

Figure 3 (Divalproex Fig3)

The text describes a graph, identified as "Figure 3", which shows the percentage of patients who experience Improvement, No Change, or Worsening on a reduced Incidents per 1000 Patient Days (InCPS) rate. The graph displays two lines representing the High Dosage and the Low Dosage categories, respectively. The X-axis represents % of patients, while the Y-axis shows the level of Improvement, No Change, or Worsening achieved through the treatment.*

FDA Label Image

Figure 4 (Divalproex Fig4)

This is a figure showing the mean frequency of migraines over a period of d weeks in two studies comparing a placebo treatment to the drug Divalproex Sodium, administered via delayed-release tablets at a mean dose of 1087mg/day in Study 1, and either 500 or 1000 mg/day in Study 2.*

FDA Label Image

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.